Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
Santa Mammana, Eugenio Cavalli, Agnese Gugliandolo, et al.
Medicina (2019) Vol. 55, Iss. 11, pp. 747-747
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The Pharmacological Case for Cannabigerol
Rahul Nachnani, Wesley M. Raup‐Konsavage, Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 376, Iss. 2, pp. 204-212
Open Access | Times Cited: 149
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Elaine Cristina Dalazen Gonçalves, Gabriela Mantovani Baldasso, Maíra A. Bicca, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1567-1567
Open Access | Times Cited: 93
Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4379-4402
Open Access | Times Cited: 9
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Inés Gallego‐Landin, Alba García-Baos, Adriana Castro‐Zavala, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
A Comprehensive Phytochemical Analysis of Terpenes, Polyphenols and Cannabinoids, and Micromorphological Characterization of 9 Commercial Varieties of Cannabis sativa L.
Eugenia Mazzara, Jacopo Torresi, Gelsomina Fico, et al.
Plants (2022) Vol. 11, Iss. 7, pp. 891-891
Open Access | Times Cited: 32
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Hydrogen Sulfide Reverses LPS-Induced Behavioral Deficits by Suppressing Microglial Activation and Promoting M2 Polarization
Mohit Kumar, Palkin Arora, Rajat Sandhir
Journal of Neuroimmune Pharmacology (2020) Vol. 16, Iss. 2, pp. 483-499
Closed Access | Times Cited: 42
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Eugenio Cavalli, Rosella Ciurleo, Maria Cristina Petralia, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1194-1194
Open Access | Times Cited: 39
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms
Ethan B. Russo, Carrie Cuttler, Ziva D. Cooper, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 706-716
Closed Access | Times Cited: 37
Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
European Journal of Pain (2022) Vol. 26, Iss. 9, pp. 1950-1966
Closed Access | Times Cited: 25
Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics
R.F. Malheiro, Helena Carmo, Félix Carvalho, et al.
Pharmacological Research (2022) Vol. 187, pp. 106603-106603
Open Access | Times Cited: 25
Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability
Mohammad‐Reza Ghovanloo, Mark Estación, Grant P. Higerd‐Rusli, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 15, pp. 4010-4030
Open Access | Times Cited: 24
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 5
Antioxidant and membrane-protective effects of the 3-O-ethyl ascorbic acid-cannabigerol system on UVB-irradiated human keratinocytes
Iwona Jarocka-Karpowicz, Anna Stasiewicz, Ewa Olchowik‐Grabarek, et al.
Free Radical Biology and Medicine (2025) Vol. 228, pp. 251-266
Closed Access
Bitter Taste Receptors as Gatekeepers of Brain Barriers
Ana Catarina Duarte, Ana R. Costa, Isabel Gonçalves, et al.
Current human cell research and applications (2025), pp. 69-83
Closed Access
The Current and Potential Application of Medicinal Cannabis Products in Dentistry
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
Dentistry Journal (2021) Vol. 9, Iss. 9, pp. 106-106
Open Access | Times Cited: 32
The druggability of bitter taste receptors for the treatment of neurodegenerative disorders
Ana Catarina Duarte, Ana R. Costa, Isabel Gonçalves, et al.
Biochemical Pharmacology (2022) Vol. 197, pp. 114915-114915
Open Access | Times Cited: 19
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3805-3805
Open Access | Times Cited: 4
The Pharmacology of Cannabinoids in Chronic Pain
Alonso Cortez-Resendiz, Timothy J Leiter, S. Riela, et al.
Medical Cannabis and Cannabinoids (2025)
Open Access
IL-37 As a Potential Biotherapeutics of Inflammatory Diseases
Junhui Bai, Yukun Li, Meixiang Li, et al.
Current Drug Targets (2020) Vol. 21, Iss. 9, pp. 855-863
Closed Access | Times Cited: 30
Receptor mechanisms mediating the anti‐neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine
Erkan Kılınç, Seyit Ankaralı, İbrahim Ethem Torun, et al.
European Journal of Neuroscience (2020) Vol. 55, Iss. 4, pp. 1015-1031
Closed Access | Times Cited: 29
Cannabidiol-Driven Alterations to Inflammatory Protein Landscape of Lipopolysaccharide-Activated Macrophages In Vitro May Be Mediated by Autophagy and Oxidative Stress
Daniel J. Yeisley, Ahmad S. Arabiyat, Mariah S. Hahn
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 3, pp. 253-263
Open Access | Times Cited: 26
Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study
Albert Stuart Reece, Gary Kenneth Hulse
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 26
The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
Michał Graczyk, Agata Anna Lewandowska, Tomasz Dzierżanowski
Molecules (2021) Vol. 26, Iss. 15, pp. 4551-4551
Open Access | Times Cited: 24
Cannabinerol (CBNR) Influences Synaptic Genes Associated with Cytoskeleton and Ion Channels in NSC-34 Cell Line: A Transcriptomic Study
Osvaldo Artimagnella, Emanuela Mazzon, Stefano Salamone, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 189-189
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top